2,5-Hexanedione induces dopaminergic neurodegeneration through integrin αMβ2/NADPH oxidase axis-mediated microglial activation
Authors:
Open Access
- 19 January 2018
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 9 (2) , 60
Abstract
Recent study demonstrated that chronic exposure to solvents increases the risk of Parkinson’s disease (PD), the second most common neurodegenerative disorder characterized by progressive dopaminergic neurodegeneration in the substantia nigra (SN). n -Hexane, a widely used organic solvent, displays central-peripheral neurotoxicity, which is mainly mediated by its active metabolite, 2,5-hexanedione (HD). However, whether HD exposure contributes to PD remains unclear. In this study, we found that rats exposed to HD displayed progressive dopaminergic neurodegeneration in the nigrostriatal system. Microglial activation was also detected in HD-treated rats, which occurred prior to degeneration of dopaminergic neurons. Moreover, depletion of microglia markedly reduced HD-induced dopaminergic neurotoxicity. Mechanistic study revealed an essential role of microglial integrin α M β 2 -NADPH oxidase (NOX2) axis in HD-elicited neurotoxicity. HD activated NOX2 by inducing membrane translocation of NOX2 cytosolic subunit, p47 phox . Integrin α M β 2 was critical for HD-induced NOX2 activation since inhibition or genetic deletion of α M β 2 attenuated NOX2-generated superoxide and p47 phox membrane translocation in response to HD. Src and Erk, two downstream signals of α M β 2 , were recognized to bridge HD/α M β 2 -mediated NOX2 activation. Finally, pharmacological inhibition of α M β 2 -NOX2 axis attenuated HD-induced microglial activation and dopaminergic neurodegeneration. Our findings revealed that HD exposure damaged nigrostriatal dopaminergic system through α M β 2 -NOX2 axis-mediated microglial activation, providing, for the first time, experimental evidence for n -hexane exposure contributing to the etiology of PD.Keywords
This publication has 63 references indexed in Scilit:
- NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administrationGlia, 2013
- Rotenone, Paraquat, and Parkinson’s DiseaseEnvironmental Health Perspectives, 2011
- Carboxyl-terminus of Hsc70 interacting protein mediates 2,5-hexanedione-induced neurofilament medium chain degradationBiochemical Pharmacology, 2011
- HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive NeurodegenerationThe Journal of Neuroscience, 2011
- Occupational and behavioural factors in the explanation of social inequalities in premature and total mortality: a 12.5-year follow-up in the Lorhandicap studyEuropean Journal of Epidemiology, 2010
- Clinical progression in Parkinson disease and the neurobiology of axonsAnnals of Neurology, 2010
- Src kinase participates in LPS-induced activation of NADPH oxidaseMolecular Immunology, 2010
- Src kinase up-regulates the ERK cascade through inactivation of protein phosphatase 2A following cerebral ischemiaBMC Neuroscience, 2009
- NADPH oxidase is the primary source of superoxide induced by NMDA receptor activationNature Neuroscience, 2009
- Requirement of α and β subunit transmembrane helix separation for integrin outside-in signalingBlood, 2007